Drug factories
Scientists engineer baker's yeast to produce penicillin molecules
Scientists have inserted fungus genes into a yeast cell to make it produce penicillin molecules.
Scientists engineer baker's yeast to produce penicillin molecules
Scientists have inserted fungus genes into a yeast cell to make it produce penicillin molecules.
Earliest relative of Brachiosaurus dinosaur found in France
Scientists have re-examined an overlooked museum fossil and discovered that it is the earliest member of the titanosauriform family of dinosaurs.
3D model of American football player's brain reconstructs moment of impact
Scientists have modelled what happens to the brain of an American footballer when he collides forcefully with another player.
Multi-million EU funding boost for Imperial researchers
The European Research Council has invested more than €15 million in a series of new grants across all four Imperial faculties.
Imperial part of £100 million Rosalind Franklin Institute
Scientists from Imperial College London will be playing a major role in a new research institute funded by the UK Government.
Scientists to create galactic building blocks to study the space between stars
Researchers are planning to synthesise a class of chemical compounds to determine whether they are an important building block for making galaxies.
Video
Brexit 1.0: scientists find evidence of Britain's separation from Europe
Researchers have found evidence of how ancient Britain separated from Europe, which happened in two stages, they report in Nature Communications.
4
Imperial recognised as a centre of excellence in cyber security research
Imperial College London has been recognised again as an academic centre of excellence in cyber security research.
Imperial celebrates long and strong relationship with Livery Companies
The relationship between Imperial's Faculty of Engineering and the City Livery Companies was celebrated at the opening of the heritage area.
3
Q&A: Imperial academic talks about juggling academia and entrepreneurialism
An Imperial start-up company was sold last year for more than £30 million and one of its founders discusses the lessons learned along the way.